Carrier Global Corporation has agreed to a substantial $730 million settlement to address claims related to its fire protection subsidiary, Kidde-Fenwal’s, use of per- and polyfluoroalkyl substances (PFAS). These chemicals, often referred to as “forever chemicals,” have come under increasing scrutiny due to their potential health risks and environmental impact. The settlement stems from numerous lawsuits alleging that Carrier’s firefighting foam products contributed to contamination and health issues, making it a significant development in the

Blue Cross Blue Shield (BCBS) has reached a hefty $2.8 billion settlement to wrap up a class-action lawsuit from healthcare providers who claimed the insurer engaged in unfair practices that hurt their reimbursement rates. This lawsuit highlighted some serious concerns about competition in the healthcare market, and the settlement is set to provide much-needed financial relief to thousands of affected providers. Beyond the money settlement, BCBS has also promised to improve their practices by creating

A tentative trial date has been established in the ongoing sex discrimination lawsuit against Nike, which accuses the company of fostering a workplace culture that discriminates against women. The suit, initiated by a former employee, alleges that female staff members were consistently overlooked for promotions and subjected to unfair pay practices compared to their male counterparts. As the case progresses, it is expected to bring significant attention to issues of gender equity within corporate environments,

A recent ruling by a U.S. District Judge has allowed a class-action lawsuit concerning hair relaxer products, specifically targeting brands like L’Oréal and Revlon, to move forward. The lawsuit claims that these manufacturers misled consumers about the safety and effectiveness of their products, with allegations that they exaggerated benefits while downplaying potential health risks linked to cancer. The lawsuit is based on a National Institutes of Health study showing that regular users of these hair

New York-based law firm Pomerantz LLP has filed a motion for preliminary approval on a $70 million settlement against Wynn Resorts Ltd. Hundreds of shareholders will split the class action settlement stemming from allegations that the company didn’t disclose the sexual misconduct of former CEO Steve Wynn. Shareholders of Wynn Resorts Ltd. allege their stock shares plummeted as a result of the 2018 sexual misconduct allegations and the failure of Wynn executives to announce any

A proposed class action against the consumer goods company Church and Dwight has been filed in Manhattan Federal court. The popular condom brand Trojan has been called out for producing unsafe products, in particular their ‘Ultra Thin’ brand of condoms for containing per-and polyfluoroalkyl substances, also known as PFAS. PFAS have become known as “forever chemicals” due to the fact that they do not break down easily in the human body or environment. These forever

A combined $57.4 million payout has been agreed upon by three meat industry giants to settle a proposed class action lawsuit. Cargill, National Beef Packing, and Hormel have been accused of suppressing wages for workers at 140 different processing plants. This decision brings the total settlement to over $200 million since the lawsuit was initiated in 2022. Tens of thousands of workers allege a years-long conspiracy among leading processors to keep wages low through the

A class action complaint was filed against Delta Airlines in the United States District Court of the Northern District of Georgia. This comes after more than 3,000 complaints against the airline were made.

After recalling more than 7 million pounds of meat products linked to a deadly listeria outbreak, Boar’s Head is now facing a potential class action lawsuit.

In an antitrust lawsuit against the NFL, a jury awarded $4.7 billion to NFL fans and $96 million to businesses who purchased the NFL’s “Sunday Ticket” packages.

Judge Karen Martson has been appointed to oversee a massive, multi-district lawsuit, against Novo Nordisk and Eli Lilly, Both drugmakers of GLP-1 class medications. Their popular diabetes and obesity medications include Ozempic, Wegovy, Mounjaro, Trulicity and Zepbound.